Nanotube interactions with microtubules: Implications for cancer medicine

Nanomedicine

Volumn 9, Issue 10, 2014, Pages 1581-1588

  García Hevia, Lorena ^a   Fernández, Fidel ^a   Grávalos, Cristina ^b   García, Almudena ^b   Villegas, Juan C ^a   Fanarraga, Mónica L ^a  

^a UNIVERSITY OF CANTABRIA   (Spain)

^b HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

Author keywords

biomimetics; biosynthetic polymers; carbon nanotubues; cell proliferation; cytoskeleton; microtubule stability; tubulin polymerization

Indexed keywords

ANTINEOPLASTIC AGENT; CARBON NANOTUBE; BIOMIMETIC MATERIAL;

APOPTOSIS; BINDING SITE; BIOMIMETICS; CANCER CELL; CANCER THERAPY; CELL DIVISION; CELL MIGRATION; CELL PROLIFERATION; CYTOSKELETON; CYTOTOXICITY; HELA CELL LINE; HUMAN; MICROTUBULE; MICROTUBULE ASSEMBLY; MITOSIS SPINDLE; NONHUMAN; REVIEW; ANIMAL; CHEMISTRY; DRUG DESIGN; NEOPLASMS; SYNTHESIS; ULTRASTRUCTURE;

ANIMALS; BIOMIMETIC MATERIALS; DRUG DESIGN; HUMANS; MICROTUBULES; NANOTUBES, CARBON; NEOPLASMS;

EID: 84907468348     PISSN: 17435889     EISSN: 17486963     Source Type: Journal    
DOI: 10.2217/nnm.14.92     Document Type: Review

References (39)

1. Mitchison T, Kirschner M. Dynamic instability of microtubule growth. Nature 312, 237-242 (1984).
2. Nogales E, Whittaker M, Milligan RA, Downing KH. High-resolution model of the microtubule. Cell 96, 79-88 (1999).
3. Chretien D, Fuller SD, Karsenti E. Structure of growing microtubule ends: two-dimensional sheets close into tubes at variable rates. J. Cell Biol. 129, 1311-1328 (1995).
4. Mitchison TJ. Localization of an exchangeable GTP binding site at the plus end of microtubules. Science 261, 1044-1047 (1993).
5. Tassin A, Bornens M. Centrosome structure and microtubule nucleation in animal cells. Biol. Cell 91, 343-354 (1999).
6. Cassimeris L, Pryer NK, Salmon ED. Real-time observations of microtubule dynamic instability in living cells. J. Cell Biol. 107, 2223-2231 (1988).
7. Desai A, Mitchison TJ. Microtubule polymerization dynamics. Annu. Rev. Cell Dev. Biol. 13, 83-117 (1997).
8. Mitchison TJ, Salmon ED. Mitosis: a history of division. Nat. Cell Biol. 3, 17-22 (2001).
9. Jones S, Zhang X, Parsons DW, et al. Core signalling pathways in human pancreatic cancers revealed by global genomic analyses. Science 321, 1801-1806 (2008).
10. Matson DR, Stukenberg PT. Spindle poisons and cell fate: a tale of two pathways. Mol. Interv. 11, 41-150 (2011).
11. Jordan MA, Wilson L. Microtubules as a target for anticancer drugs. Nat. Rev. Cancer 4, 253-265 (2004).
12. Zhou J, Giannakakou P. Targeting microtubules for cancer chemotherapy. Curr. Med. Chem. Anti-Cancer Agents 5, 65-71 (2005).
13. Jordan M. Mechanism of action of antitumour drugs that Interact with microtubules and tubulin. Curr. Med. Chem. 2(1), 1-17 (2012).
14. Chen J, Liu T, Dong X, Hu Y. Recent development and SAR analysis of colchicine binding site inhibitors. Mini Rev. Med. Chem. 9, 1174-1190 (2009).
15. Gidding CE, Kellie SJ, Kamps WA, de Graaf SS. Vincristine revisited. Crit. Rev. Oncol. Hematol. 29, 267-287 (1999).
16. De Brabander M, Geuens G, Nuydens R, Willebrords R, De Mey J. Taxol induces the assembly of free microtubules in living cells and blocks the organizing capacity of the centrosomes and kinetochores. Proc. Natl. Acad. Sci. USA 78, 5608-5612 (1981).
17. Alberti C. Cytoskeleton structure and dynamic behavior: quick excursus from basic molecular mechanisms to some implications in cancer chemotherapy. Eur. Rev. Med. Pharmacol. Sci. 13, 13-21 (2009).
18. Alberti C. Taxane-and epothilone-based chemotherapy: from molecule cargo cytoskeletal logistics to management of castration-resistant prostate carcinoma. Eur. Rev. Med. Pharmacol. Sci. 17, 1658-1664 (2013).
19. Kowalski RJ, Giannakakou P, Hamel E. Activities of the microtubule-stabilizing agents epothilones A and B with purified tubulin and in cells resistant to paclitaxel (Taxol®). J. Biol. Chem. 272, 2534-2541 (1997).
20. Sarbia M, Bittinger F, Porschen R, et al. The prognostic significance of tumour cell proliferation in squamous cell carcinomas of the oesophagus. Br. J. Cancer 74, 1012-1016 (1996).
21. Orr GA, Verdier-Pinard P, McDaid H, Horwitz SB. Mechanisms of Taxol resistance related to microtubules. Oncogene 22, 7280-7295 (2003).
22. Smith JA, Wilson L, Azarenko O, et al. Eribulin binds at microtubule ends to a single site on tubulin to suppress dynamic instability. Biochemistry 49, 1331-1337 (2010).
23. McBride A, Butler SK. Eribulin mesylate: a novel halichondrin B analogue for the treatment of metastatic breast cancer. Am. J. Health Syst. Pharm. 69, 745-755 (2012).
24. Huang HC, Shi J, Orth JD, Mitchison TJ. Evidence that mitotic exit is a better cancer therapeutic target than spindle assembly. Cancer Cell 16, 347-358 (2009).
25. Pampaloni F, Florin EL. Microtubule architecture: inspiration for novel carbon nanotube-based biomimetic materials. Trends Biotechnol. 26, 302-310 (2008).
26. Dinu CZ, Bale SS, Zhu G, Dordick JS. Tubulin encapsulation of CNTs into functional hybrid assemblies. Small 5, 310-315 (2009).
27. Dinu CZ, Bale SS, Dordick JS. Kinesin I. ATPase manipulates biohybrids formed from tubulin and carbon nanotubes. Methods Mol. Biol. 743, 77-93 (2011).
28. Rodríguez-Fernández L, Valiente R, González J, Villegas JC, Fanarraga ML. Multiwalled carbon nanotubes display microtubule biomimetic properties in vivo, enhancing microtubule assembly and stabilization. ACS Nano 6, 6614-6625 (2012).
29. Sargent LM, Hubbs AF, Young SH, et al. Single-walled carbon nanotube-induced mitotic disruption. Mutat. Res. 745, 28-37 (2012).
30. Shams H, Holt BD, Mahboobi SH, et al. Actin reorganization through dynamic interactions with singlewall carbon nanotubes. ACS Nano 8, 188-197 (2014).
31. Gonzalez L, Decordier I, Kirsch-Volders M. Induction of chromosome malsegregation by nanomaterials. Biochem. Soc. Trans. 38, 1691-1697 (2010).
32. Sargent LM, Hubbs AF, Young SH, et al. Single-walled carbon nanotube-induced mitotic disruption. Mutat. Res. 745, 28-37 (2012).
33. Li X, Peng Y, Ren J, Qu X. Carboxyl-modified single-walled carbon nanotubes selectively induce human telomeric i-motif formation. Proc. Natl Acad. Sci. USA 103, 19658-632006 (2006).
34. Lindberg HK, Falck GC, Singh R, et al. Genotoxicity of short single-wall and multi-wall carbon nanotubes in human bronchial epithelial and mesothelial cells in vitro. Toxicology 313, 24-37 (2013).
35. Kuang Y, Xu B. Disruption of the dynamics of microtubules and selective inhibition of glioblastoma cells by nanofibers of small hydrophobic molecules. Angew. Chem. Int. Ed. Engl. 52, 6944-6948 (2013).
36. Villegas JC, Álvarez-Montes L, Rodríguez-Fernández L, González J, Valiente R, Fanarraga ML. Multiwalled carbon nanotubes hinder microglia function interfering with cell migration and phagocytosis. Adv. Healthc. Mater. 3, 424-432 (2014).
37. Dong C, Kashon ML, Lowry D, et al. Exposure to carbon nanotubes leads to changes in the cellular biomechanics. Adv. Healthc. Mater. 2, 945-951 (2013).
38. Wang J, Xu Y, Yang Z, et al. Toxicity of carbon nanotubes. Curr. Drug Metab. 14, 891-899 (2013).
39. Lanone S, Andujar P, Kermanizadeh A, Boczkowski J. Determinants of carbon nanotube toxicity. Adv. Drug Deliv. Rev. 65, 2063-2069 (2013).